A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2014
At a glance
- Drugs Testosterone (Primary)
- Indications Ejaculation disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 29 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 10 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jul 2013 Planned End Date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.